Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 02, 2022

SELL
$5.28 - $18.9 $3.81 Million - $13.6 Million
-721,114 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$12.92 - $27.18 $878,934 - $1.85 Million
68,029 Added 10.42%
721,114 $12.7 Million
Q4 2021

Feb 08, 2022

SELL
$21.96 - $42.69 $5.92 Million - $11.5 Million
-269,687 Reduced 29.23%
653,085 $17.2 Million
Q3 2021

Nov 09, 2021

BUY
$41.3 - $54.56 $6.06 Million - $8 Million
146,657 Added 18.9%
922,772 $38.9 Million
Q2 2021

Aug 12, 2021

SELL
$38.61 - $55.0 $218,262 - $310,915
-5,653 Reduced 0.72%
776,115 $42.2 Million
Q1 2021

May 11, 2021

BUY
$38.1 - $59.09 $5.26 Million - $8.15 Million
137,992 Added 21.43%
781,768 $35.5 Million
Q4 2020

Feb 05, 2021

BUY
$33.26 - $59.72 $9.9 Million - $17.8 Million
297,767 Added 86.06%
643,776 $28 Million
Q3 2020

Nov 04, 2020

BUY
$0.55 - $41.34 $190,304 - $14.3 Million
346,009 New
346,009 $13.4 Million

Others Institutions Holding ACCD

About Accolade, Inc.


  • Ticker ACCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 71,938,896
  • Market Cap $248M
  • Description
  • Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...
More about ACCD
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.